Felicia Pagliuca
Founder at Semma Therapeutics, Inc.
Felicia Pagliuca active positions
| Companies | Position | Start | End |
|---|---|---|---|
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/01/2015 | - |
| Founder | 01/01/2015 | - |
Career history of Felicia Pagliuca
Training of Felicia Pagliuca
| Duke University | Undergraduate Degree |
| University of Cambridge | Doctorate Degree |
Statistics
International
| United States | 3 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Felicia Pagliuca
- Experience
